News

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, announced the findings of a survey conducted at its spring conference. The results show that almost half (47%) of respondents believe that workplace...

Innovation Pharmaceuticals, a clinical stage biopharmaceutical company, announced that it has achieved full patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 clinical trial of Brilacidin for the treatment of moderate-to-severe COVID-19 in hospitalized patients. Innovation Pharmaceuticals is developing...

Centivax has signed a strategic collaboration with the US Naval Medical Research Center (NMRC) to conduct Phase I clinical development of its SARS-CoV-2 antibody, Centi-B9. Centi-B9 is designed as a broad-spectrum therapeutic and prophylactic for administration through injections. It is...

The U.K.’s medicines regulator on Friday approved Janssen’s single-dose Covid-19 vaccine for use. Britain’s Medicines and Healthcare products Regulatory Agency said that doses were expected to be available in the U.K. later this year. The British government’s Vaccine Taskforce has...

In fact, it’s not just this particular bug that we need to be concerned about. There are other cousins of mucor lurking in our environment, waiting for the perfect storm of a host to take residence in. Ever wonder...

CovidAsha, a chatbot platform on the Web, WhatsApp and Telegram, is a unique initiative by conversational automation heavy-weights Engati, and healthcare ecosystem players like Pharmeasy, VMedo, StanPlus and The Better India, with WhatsApp providing the platform. CovidAsha was born out...

Onyx Scientific, a small molecule API contract development and manufacturing organisation has received a commercial API license for its UK facility. The license, granted by the Medicines and Healthcare Products Regulatory Agency (MHRA), allows Onyx to support API projects from...